We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

Back to rankings

25 hedge funds and large institutions have $3.61M invested in Sophiris Bio, Inc. in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less call options, than puts

Call options by funds: $131K | Put options by funds: $135K

11% less capital invested

Capital invested by funds: $4.07M → $3.61M (-$457K)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

19% less funds holding

Funds holding: 31 → 25 (-6)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
25
Holders Change
-6
Holders Change %
-19.35%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
6
Closed
8
Calls
$131K
Puts
$135K
Net Calls
-$4K
Net Calls Change
+$204K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$92.8K
2
Citadel Advisors
Citadel Advisors
Florida
+$76.1K
3
VF
Virtu Financial
New York
+$71.8K
4
GC
Guggenheim Capital
Illinois
+$22.7K
5
Bank of America
Bank of America
North Carolina
+$6.84K

Top Sellers

Rank Fund Capital Flow
1
Squarepoint
Squarepoint
New York
-$183K
2
MFIM
Mesirow Financial Investment Management
Illinois
-$120K
3
GCP
GSA Capital Partners
United Kingdom
-$84K
4
SM
Sabby Management
Florida
-$50K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$46.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.66M +$92.8K +44,768 +6%
SM
2
Sabby Management
Florida
$716K -$50K -24,151 -7%
PAI
3
Palo Alto Investors
California
$530K – – –
BlackRock
4
BlackRock
New York
$163K -$8.98K -4,334 -5%
JP Morgan Chase
5
JP Morgan Chase
New York
$129K -$3.3K -1,593 -7%
Citadel Advisors
6
Citadel Advisors
Florida
$79K +$76.1K +36,721 New
VF
7
Virtu Financial
New York
$74K +$71.8K +34,671 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$40K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$38K -$31 -15 -0.1%
CAN
10
Cetera Advisor Networks
California
$32K – – –
GC
11
Guggenheim Capital
Illinois
$23K +$22.7K +10,975 New
ACM
12
Alpha Capital Management
Texas
$22K – – –
LWAC
13
Laurel Wealth Advisors (California)
California
$21K – – –
LPL Financial
14
LPL Financial
California
$21K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$15K +$12 +6 +0.1%
UBS Group
16
UBS Group
Switzerland
$12K -$1.01K -488 -8%
Morgan Stanley
17
Morgan Stanley
New York
$11K +$4.14K +2,000 +67%
AG
18
Advisor Group
Arizona
$7K +$191 +92 +3%
Bank of America
19
Bank of America
North Carolina
$7K +$6.84K +3,300 +8,684%
EWM
20
Edge Wealth Management
New York
$4K – – –
Wells Fargo
21
Wells Fargo
California
$4K – – –
FANJ
22
Financial Architects (New Jersey)
New Jersey
$2K – – –
JCM
23
Jacobi Capital Management
Pennsylvania
$1K – – –
FDCDDQ
24
Federation des caisses Desjardins du Quebec
Quebec, Canada
$391 – – –
Squarepoint
25
Squarepoint
New York
– -$183K -83,100 Closed
1
2

SPHS Hedge Fund Activity: Q3 2017 in Review

25 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q3 2017, worth a combined $3.61M — down 11% from $4.07M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of SPHS and 3 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 5 added.

The largest buyer was Vanguard Group, adding an estimated $92.8K. The largest seller was Squarepoint, exiting entirely with an estimated $183K sold.

  • 25 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q3 2017, down from 31 in Q2 2017.
  • Funds reported $3.61M of Sophiris Bio, Inc. stock for Q3 2017, down 11% quarter-over-quarter.
  • 3 funds opened new Sophiris Bio, Inc. positions in Q3 2017 and 8 closed out, a net change of -5 holders.
  • The largest Sophiris Bio, Inc. buyer in Q3 2017 was Vanguard Group, an estimated $92.8K added.
  • The largest Sophiris Bio, Inc. seller in Q3 2017 was Squarepoint, an estimated $183K sold.

Based on aggregated 13F filings for Q3 2017.